We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.1B
AUM Growth
+$1.41B
Cap. Flow
+$185M
Cap. Flow %
1.31%
Top 10 Hldgs %
55.94%
Holding
1,091
New
131
Increased
431
Reduced
407
Closed
118

Sector Composition

Rank Sector Weight
1 Energy 67.18%
2 Technology 4.4%
3 Healthcare 3.48%
4 Financials 3.41%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPBD icon
576
Upbound Group
UPBD
$1.2B
$570K ﹤0.01%
16,189
-532
-3% -$17.8K
INVH icon
577
Invitation Homes
INVH
$17.6B
$568K ﹤0.01%
15,944
-524
-3% -$17.7K
LIN icon
578
Linde
LIN
$234B
$563K ﹤0.01%
1,213
-62
-5% -$26.8K
AVA icon
579
Avista
AVA
$3.43B
$560K ﹤0.01%
16,000
+2,430
+18% +$82.8K
KNSA icon
580
Kiniksa Pharmaceuticals
KNSA
$4.89B
$556K ﹤0.01%
28,203
-13,693
-33% -$267K
BF.B icon
581
Brown-Forman Class B
BF.B
$12.6B
$547K ﹤0.01%
10,589
+136
+1% +$7.57K
CIB icon
582
Grupo Cibest SA
CIB
$20.9B
$546K ﹤0.01%
15,944
-4,412
-22% -$143K
CTRA
583
DELISTED
Coterra Energy
CTRA
$536K ﹤0.01%
19,211
-12,135
-39% -$311K
UBS icon
584
UBS Group
UBS
$172B
$533K ﹤0.01%
17,341
-889
-5% -$26.3K
GEF.B icon
585
Greif Class B
GEF.B
$3.8B
$531K ﹤0.01%
7,635
-251
-3% -$16.1K
ALLO icon
586
Allogene Therapeutics
ALLO
$604M
$531K ﹤0.01%
118,686
+32
+0% +$134
JD icon
587
JD.com
JD
$41.8B
$521K ﹤0.01%
19,026
+1,257
+7% +$30.8K
AUPH icon
588
Aurinia Pharmaceuticals
AUPH
$1.96B
$511K ﹤0.01%
102,006
+1,482
+1% +$10.1K
DHIL
589
DELISTED
Diamond Hill
DHIL
$505K ﹤0.01%
3,274
+486
+17% +$75.7K
FULT icon
590
Fulton Financial
FULT
$4.67B
$502K ﹤0.01%
31,596
-26,183
-45% -$409K
UAL icon
591
United Airlines
UAL
$39.1B
$501K ﹤0.01%
10,461
+1,440
+16% +$61.7K
RDY icon
592
Dr. Reddy's Laboratories
RDY
$9.8B
$499K ﹤0.01%
34,010
-7,465
-18% -$109K
VLY icon
593
Valley National Bancorp
VLY
$7.94B
$499K ﹤0.01%
62,656
-37,282
-37% -$332K
MP icon
594
MP Materials
MP
$7.68B
$485K ﹤0.01%
33,883
-3,010
-8% -$47.6K
DVN icon
595
Devon Energy
DVN
$49.8B
$478K ﹤0.01%
9,531
-6,561
-41% -$291K
PPL
596
PPL Corp
PPL
$27.1B
$477K ﹤0.01%
+17,320
New +$461K
SVRA icon
597
Savara
SVRA
$1.11B
$475K ﹤0.01%
95,462
+4,543
+5% +$22K
MGM icon
598
MGM Resorts International
MGM
$11.8B
$469K ﹤0.01%
+9,936
New +$434K
FNB icon
599
FNB Corp
FNB
$6.71B
$465K ﹤0.01%
33,007
-29,864
-48% -$402K
SLRN
600
DELISTED
ACELYRIN
SLRN
$463K ﹤0.01%
68,659
+4,032
+6% +$30.6K

Similar funds

ALPS Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, ALPS Advisors held 1,091 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

ALPS Advisors's Q1 2024 filing shows 131 new, 431 increased, 407 reduced and 118 closed positions. Its largest new stake was Arcadium Lithium plc: 2,185,225 shares worth $9.42M. The largest sale was Western Midstream Partners, an estimated $67.6M.

By sector, the portfolio is most concentrated in Energy at 67% of assets, up from 66% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q1 2024 buy was Arcadium Lithium plc: 2,185,225 shares worth $9.42M.
  • ALPS Advisors added most to Hess Midstream in Q1 2024, an estimated $74.3M increase.
  • ALPS Advisors's biggest Q1 2024 reduction was Western Midstream Partners, cutting an estimated $67.6M.
  • ALPS Advisors fully exited Livent Corporation in Q1 2024, selling an estimated $11.8M.
  • ALPS Advisors's ten largest holdings make up 56% of its $14.1B portfolio in Q1 2024.
  • ALPS Advisors opened 131 new positions and closed 118 in Q1 2024.
  • ALPS Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.

Based on ALPS Advisors's 13F filing for Q1 2024, filed 14 May 2024.